Federico Ballacci

Jul 4, 2024 | onlinelibrary.wiley.com | Massimiliano Camilli |Valentina Rossi |Antonio Cannata |Federico Ballacci

Introduction Iron deficiency (ID) is common in patients with cardiovascular diseases.1 It is associated with higher mortality and recurrent hospitalizations in patients with heart failure (HF), independently of haemoglobin levels.1 Notably, compared to placebo, supplementation with intravenous iron has been demonstrated to reduce the risk of HF hospitalization and mortality in numerous randomized clinical trials,2-7 leading to the introduction of ferric compounds in published HF...